Contract 75A50123F33005
Allucent Government Services (Us) Llc · Department Of Health And Human Services · September 11, 2024
Allucent Government Services (Us) Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 11, 2024 for $26.43 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Houston, TX. This is a task or delivery order issued under parent IDIQ 75A50120D00016. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on December 11, 2025. If all options are exercised, the contract could reach $370.06 million.
Contract details
- PIID
- 75A50123F33005
- Parent IDIQ
- 75A50120D00016
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Houston, TX
- First action
- September 11, 2024
- Latest action
- December 11, 2025
Description
CLINICAL TRIAL PLANNING AND EXECUTION- COVID NEXT GENERATION VACCINE
Modification timeline
-
December 11, 2025Mod P00008 · Other Administrative Action$370.06M
-
September 24, 2024Mod P00004 · Supplemental Agreement For Work Within Scope$370.06M
-
September 11, 2024Mod P00003 · Other Administrative ActionTHE PURPOSE OF THE MODIFICATION IS TO DEOBLIGATE FUNDING FROM CLIN 0001 (LABOR) AND CLIN 0002 (ODC).$675.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50123F33005?
Contract 75A50123F33005 is a federal contract awarded to Allucent Government Services (Us) Llc by Department Of Health And Human Services on September 11, 2024 for $26.43 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75A50123F33005?
Allucent Government Services (Us) Llc won contract 75A50123F33005 from Department Of Health And Human Services.
How much is contract 75A50123F33005 worth?
Contract 75A50123F33005 has obligated $26.43 million to date, with a total potential value of $370.06 million if all options are exercised.